Bahleda, Rastislav External Author

Publications

Sort by

Selected publications

  • Phase I-IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumoursEuropean Journal of Cancer2013 Academic Article GET IT
    Times cited: 12